Clindamycin






121 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 29219 Emergence of multiply resistant pneumococci. N Engl J Med 1978 Oct 5 1
2 438530 Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Infect Dis 1979 Jan 1
3 1294622 Antimicrobial agents induce monocytes to release IL-1 alpha, IL-6, and TNF, and induce lymphocytes to release IL-4 and TNF tau. Immunopharmacol Immunotoxicol 1992 2
4 1507452 [Methicillin-resistant Staphylococcus aureus (MRSA) isolated in hospitals in Fukuoka City area]. Nihon Rinsho 1992 May 1
5 2163244 Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1990 May 1
6 2380767 Clindamycin in the treatment of an outbreak of streptococcal pharyngitis in a kibbutz due to beta-lactamase producing organisms. J Chemother 1990 Jun 1
7 2500139 Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora. Arch Otolaryngol Head Neck Surg 1989 Jul 1
8 2527734 Effects of clindamycin and cefuroxime on leukocyte membrane receptors and function. Chemotherapy 1989 2
9 2575870 Immunological alterations in uncomplicated Plasmodium falciparum malaria. Relationship between parasitaemia and indicators of macrophage activation. Acta Trop 1989 Oct 1
10 2767221 Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains. Eur J Epidemiol 1989 Jun 1
11 3020254 The effect of clindamycin on macrophage and monocyte Fc receptors. J Clin Lab Immunol 1986 Aug 1
12 3137275 Interferon-gamma and antibiotics fail to act synergistically to kill Legionella pneumophila in human monocytes. J Interferon Res 1988 Jun 1
13 3144525 In-vitro and in-vivo bacterocodal interactions of clindamycin and ceftazidime, by non-beta-lactamase mechanisms, in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive beta-lactamase overproducing strain. J Antimicrob Chemother 1988 Oct 3
14 3169291 Reproductive outcome after medical management of complicated pelvic inflammatory disease. Fertil Steril 1988 Oct 1
15 3492375 Influence of antibiotics on intestinal mucin in healthy subjects. Eur J Clin Microbiol 1986 Dec 1
16 4779693 Evaluation of clindamycin in group A beta haemolytic streptococcal infections in children. Acta Paediatr Belg 1973 1
17 6315672 Influence of clindamycin on fibronectin-staphylococcal interactions. J Antimicrob Chemother 1983 Oct 5
18 6414365 Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa. Antimicrob Agents Chemother 1983 Jul 1
19 7014632 Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 1981 May 2
20 7096266 Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis. J Bacteriol 1982 Aug 3
21 7265601 [Effects of some kinds of antibiotics on the electrical and mechanical activities of guinea-pig taenia coli (author's transl)]. Nihon Heikatsukin Gakkai Zasshi 1980 Jun 2
22 7492105 In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule. Antimicrob Agents Chemother 1995 Jul 1
23 7920440 Inhibitory effect of clindamycin on production of beta-lactamase in beta-lactam-resistant bacteria. Biol Pharm Bull 1994 May 5
24 8492751 Fever and granulocytopenia in children with cancer: a study of 299 episodes with two treatment protocols in Brazil. Med Pediatr Oncol 1993 1
25 8559623 Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995 Sep 1
26 8723488 In vitro and in vivo immunomodulatory effects of anti-Pneumocystis carinii drugs. Antimicrob Agents Chemother 1996 May 1
27 9011117 Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases. Kansenshogaku Zasshi 1996 Dec 3
28 9055997 In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrob Agents Chemother 1997 Mar 1
29 9789363 [Frequency and antibiotic susceptibility of oxacillin resistant Staphylococcus aureus in a teaching hospital]. Zentralbl Hyg Umweltmed 1998 Sep 1
30 10049276 Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta. Antimicrob Agents Chemother 1999 Mar 2
31 10348770 Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis. Antimicrob Agents Chemother 1999 Jun 1
32 11144420 Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998. Microb Drug Resist 2000 Fall 1
33 11292717 Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun 2001 May 1
34 11502543 Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines. Antimicrob Agents Chemother 2001 Sep 3
35 11760173 Invasive Salmonella virchow infection in childhood. Scand J Infect Dis 2001 1
36 12019067 Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA. Antimicrob Agents Chemother 2002 Jun 1
37 12814964 In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metab Dispos 2003 Jul 3
38 15095923 Influence of clindamycin, metronidazole and polymyxin B on the expression of cell adhesion molecules stimulated by endotoxin and enterotoxin of Bacteroides fragilis. Acta Microbiol Pol 2003 5
39 15182732 Differential effects of clindamycin on neutrophils of healthy donors and septic patients. Int Immunopharmacol 2004 Jul 1
40 15635047 Group B streptococci exposed to rifampin or clindamycin (versus ampicillin or cefotaxime) stimulate reduced production of inflammatory mediators by murine macrophages. Pediatr Res 2005 Mar 3
41 15795123 Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci 2005 Apr 1
42 16091044 A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 2005 Aug 3
43 16341337 Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan. J Microbiol Immunol Infect 2005 Dec 1
44 16439092 Rapid determination of clindamycin in medicine with myoglobin-luminol chemiluminescence system. J Pharm Biomed Anal 2006 May 3 3
45 16490583 Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther 2006 Jan 2
46 16617002 Separation and characterization of clindamycin and related impurities in bulk drug by high-performance liquid chromatography-electrospray tandem mass spectrometry. J Pharm Biomed Anal 2006 Jun 16 2
47 16771232 An alternative high-performance liquid chromatographic method for determination of clindamycin in plasma. Southeast Asian J Trop Med Public Health 2006 Jan 1
48 16940078 Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice. Antimicrob Agents Chemother 2006 Nov 1
49 17083011 Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 2006 Dec 1 2
50 17288904 [Detection of inducible resistance to clindamycin in cutaneous isolates of Staphylococcus spp. by phenotypic and genotypic methods]. Enferm Infecc Microbiol Clin 2007 Feb 1